Comparison of adjuvant activity of N- and C-terminal domain of gp96 in a Her2-positive breast cancer model

N-terminally fusion of Her2/neu to HSP70 decreases efficiency of Her2/neu DNA vaccine

(2010) Nafiseh Pakravan et al.   CELL STRESS & CHAPERONES

Co-administration of GP96 and Her2/neu DNA vaccine in a Her2 breast cancer model

(2010) Nafiseh Pakravan et al.   CELL STRESS & CHAPERONES

GP96C-terminal improves Her2/neuDNA vaccine

(2010) Nafiseh Pakravan et al.   JOURNAL OF GENE MEDICINE

HPV16 Tumor Associated Macrophages Suppress Antitumor T Cell Responses

(2009) A. P. Lepique et al.   CLINICAL CANCER RESEARCH

Cutting Edge: Tumor-Specific CD8+ T Cells Infiltrating Prostatic Tumors Are Induced to Become Suppressor Cells

(2009) K. A. Shafer-Weaver et al.   JOURNAL OF IMMUNOLOGY

Negative Feedback Regulation of IFN-  Pathway by IFN Regulatory Factor 2 in Esophageal Cancers

(2008) Y. Wang et al.   CANCER RESEARCH

Signatures Associated with Rejection or Recurrence in HER-2/neu-Positive Mammary Tumors

(2008) A. Worschech et al.   CANCER RESEARCH

Tumor Escape Mechanism Governed by Myeloid-Derived Suppressor Cells

(2008) S. Nagaraj et al.   CANCER RESEARCH

Heat-shock protein-based vaccines for cancer and infectious disease

(2008) Robert J Binder   Expert Review of Vaccines

Does HER‐2/neu antigen loss in metastatic breast tumors occur under immune pressure?

(2008) Masoud H. Manjili et al.   INTERNATIONAL JOURNAL OF CANCER